ArticleDigital health
VisualR: A novel and scalable solution for assessing visual function using virtual reality.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Diagnosis and treatment of progressive eye diseases require effective monitoring of visual structure and function. However, current methods for measuring visual function are limited in accuracy, reliability, and usability. We propose a novel approach that leverages virtual reality (VR) technology to overcome these challenges, enabling more comprehensive measurements of visual function endpoints. Methods: We developed VisualR, a low-cost VR-based application that consists of a smartphone app and a simple VR headset. The virtual environment allows precise control of visual stimuli, including the field of view, separation of visual input to the left and right eyes, control of visual angles and blocking of background visual noise. We developed novel tests for metamorphopsia, contrast sensitivity and reading speed that can be performed by following simple instructions and providing verbal responses to visual cues, without expert supervision. The smartphone app operates offline and processes all data locally. Results: We conducted empirical evaluations, including measurements of screen luminance, and performed simulations of psychometric functions to test the feasibility of building a visual function test device using widely available, inexpensive consumer-grade hardware. Our findings demonstrate the technical viability of this approach, and its potential to measure visual function endpoints during clinical development of new treatments or to support disease diagnosis and monitoring. We open-sourced the VisualR application code and provide guidelines for creating reliable and user-friendly VR-based tests. Conclusion: Our results suggest that VR technology can open a new paradigm in visual function testing, and invite the wider community to build upon our work. Author summary: Visual function describes how well the eyes can see and process basic visual information. Testing visual function is important for diagnosing and treating eye diseases that can affect vision, but current methods for measuring it are often unreliable or too complex to be performed by users without professional assistance. We propose a novel approach that uses VR technology to enable affordable and user-friendly assessments of visual function. We developed VisualR, a VR-based application that runs on a smartphone together with a simple VR headset. VisualR enables users to perform various vision function tests by following simple instructions and providing verbal responses to the visual stimuli displayed on the screen. As VisualR is smartphone-based, it eliminates the need for costly or specialized equipment. Our work demonstrates the technical feasibility and potential of creating affordable, accessible VR-based visual test devices. We open-sourced the code of VisualR and invite the broader community to build upon this work.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.